Author

Jolanta Skarbaliene

Observed names: J Skarbaliene, J. Skarbaliene, JOLANTA SKARBALIENE, Skarbaliene, Jolanta

Observed institution: Zealand Pharma (Denmark)

ORCID: 0000-0003-3965-7504

Observed ORCID: 0000-0003-3965-7504

OpenAlex ID: A5014807421

Dapiglutide, a novel dual GLP‐1 and GLP‐2 receptor agonist, attenuates intestinal insufficiency in a murine model of short bowel

2021 · Johannes Reiner, Peggy Berlin, et al. · Journal of Parenteral and Enteral Nutrition · 46

PDF

The dual GLP‐1 and GLP‐2 receptor agonist dapiglutide promotes barrier function in murine short bowel

2022 · Johannes Reiner, Johanna Thiery, et al. · Annals of the New York Academy of Sciences · 26

PDF

The anti-diabetic effects of GLP-1-gastrin dual agonist ZP3022 in ZDF rats

2015 · Jolanta Skarbaliene, Thomas Secher, et al. · Peptides · 25

Glepaglutide, a novel glucagon-like peptide-2 agonist, has anti-inflammatory and mucosal regenerative effects in an experimental model of inflammatory bowel disease in rats

2023 · Jolanta Skarbaliene, Jesper Mosolff Mathiesen, et al. · BMC Gastroenterology · 17

PDF

Development of Petrelintide: a Potent, Stable, Long-Acting Human Amylin Analogue

2025 · Henrik Fischer Munch, Rasmus Just, et al. · Journal of Medicinal Chemistry · 16

PDF

The long-acting amylin/calcitonin receptor agonist ZP5461 suppresses food intake and body weight in male rats

2021 · Lauren M. Stein, Lauren E. McGrath, et al. · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · 13

In-vitro and in-vivo studies supporting the therapeutic potential of ZP3022 in diabetes

2017 · Jolanta Skarbaliene, Kristoffer T. Rigbolt, et al. · European Journal of Pharmacology · 7

Short- versus Long-Term, Gender and Species Differences in the Intestinotrophic Effects of Long-Acting Glucagon-Like Peptide 2 Analog

2022 · P Glerup, K Sonne, et al. · Physiological Research · 6

PDF

Creating Glepaglutide, the First Long-Acting GLP-2 Analogue to Enable a Ready-to-Use Injection

2025 · Bjarne Due Larsen, Jesper Skodborg Villadsen, et al. · Journal of Medicinal Chemistry · 5

Modeling energy intake and body weight effects of a long-acting amylin analogue

2017 · Annika Brings, Jens Markus Borghardt, et al. · Journal of Pharmacokinetics and Pharmacodynamics · 5

Exploring the therapeutic potential of Glucagon/GLP-1 dual agonist ZP2929 in a mouse model of diet induced and biopsy-confirmed non-alcoholic steatohepatitis

2017 · J. Skarbaliene, A.N. Madsen, et al. · Journal of Hepatology · 3

ZP1848, a Novel GLP-2 Agonist, Provides a Wide Window of Therapeutic Efficacy in the Experimental Crohn's Disease Model

2011 · Jolanta Skarbaliene, Yvette M. Petersen, et al. · Gastroenterology · 2

PDF

1406-P: ZP8396, a Novel Amylin Analogue, Induces Weight Loss in DIO Rats with a Formulation Space at Physiological pH

2022 · JOLANTA SKARBALIENE, JOAKIM LUNDQVIST, et al. · Diabetes · 1

Comments on “Pharmacological Characterization of Apraglutide a Novel Long-Acting Peptidic Glucagon-Like Peptide-2 Agonist for the Treatment of Short Bowel Syndrome”

2021 · Jolanta Skarbaliene, Bjarne Due Larsen, et al. · Journal of Pharmacology and Experimental Therapeutics · 1

PDF

PT01.2: ZP7570: A Novel GLP-1/GLP-2 Dual Acting Peptide with Potential as the Next Generation Therapy for Short Bowel Syndrome

2019 · J. Skarbaliene, W. Russell, et al. · Clinical Nutrition · 1

Creating Glepaglutide: The First Long-Acting GLP-2 Analogue to enable a Ready-to-Use Subcutaneous Injection

2025 · Bjarne Due Larsen, Jesper Skodborg Villadsen, et al. · Intestinal failure.

PDF

213-OR: Antidiabetic Potential of Novel, Long-Acting Amylin Analogue ZP8396 in ZDF Rats

2022 · JOLANTA SKARBALIENE, TAMARA BAADER-PAGLER, et al. · Diabetes

Acute intestinotrophic effects of short and long-acting glp-2 analogues in rats

2021 · J. Skarbaliene, M. Berner-Hansen · Clinical Nutrition ESPEN

The Novel GLP-1-Gastrin Dual Agonist ZP3022 Improves Glycemic Control in ZDF Rats

2012 · Jolanta Skarbaliene, Jakob L. Tolborg, et al.

Works count: 22

Citation count: 174

H-index: 7

I10-index: 6